中文

News & Events

Target Health and dMed Biopharmaceuticals Join Forces to Help Western and Chinese Biopharma and Devic...2019-06-26

SHANGHAI and NEW YORK, June 24, 2019 /PRNewswire/ -- Target Health Inc. and dMed Biopharmaceuticals Company Limited have joined forces to help Western and Chinese biopharma and device companies capital...

Read More

dMed Biopharmaceutical announced the opening of its US Regulatory Affairs office in Washington DC2019-06-24

WASHINGTON, June 19, 2019 /PRNewswire/ -- Since the China launch earlier this year of an immuno-oncology drug at one-third the price of Merck's Keytruda, there has been a wave of applications for affor...

Read More

HOW CHINA IS CHANGING THE CLINICAL DEVELOPMENT LANDSCAPE2019-06-24

In less than 24 months, China has radically altered the global clinical development landscape, creating new pathways to commercialization that alter the traditional drug development paradigm.

Read More

dMed Forum in BioBay2019-03-28

dMed Forum was held successfully on March 20th in Suzhou BioBay, co-sponsored by dMed Biopharmaceutical Co., Ltd. & Suzhou Industry Park Pharmaceutical Association (SIPPA: http://www.sippa.org.cn/ ).

Read More

Lingshi Tan – Founder, Chairman and CEO, dMed, China2019-03-18

Dr Lingshi Tan, chairman and CEO of dMed, shares his strategic insights into the new era of Chinese biotech innovation and how it motivated him to leave Pfizer to establish dMed……

Read More

Interview with Dr. Lingshi Tan by Pharmaceutical Executive (Pharma Exec)—— Drug Regulatory Reform in...2019-03-05

In recent years, the regulatory environment for drugs has undergone tremendous changes in China – from rapid developments in the regulatory system to collaborating with more advanced regulatory systems...

Read More

Conference Report ——Training Course of Population Pharmacokinetics & Phase I PK/PD Clinical Trial2019-02-18

From December 26-27, 2018, the population pharmacokinetics (pop-PK) and Phase I of PK/PD clinical trial training courses were successfully completed in Shanghai

Read More

dMed in 3rd Annual China Biomed Innovation and Investment Conference2018-11-21

The 3rd Annual China BioMed Innovation and Investment Conference, jointly sponsored by China Pharmaceutical Innovation and Research Development Association (PhIRDA) and other industry associations, was...

Read More

298 Xiangke Road, 3/F, 301-305, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201210, China
Tel: +86 21 5090 0085 Fax: +86 21 6875 5515
沪ICP备16041651号-1 Copyright © 2016 dMed All Rights Reserved
沪公网安备 31011502005403号